GLP-1 (Semaglutide)
Body CompositionSignificant weight loss via appetite suppression and metabolic improvement.
GLP-1 receptor agonist that delays gastric emptying and activates hypothalamic satiety centers to suppress appetite.
For athletes, the primary value of GLP-1 (Semaglutide) lies in its ability to significant weight loss via appetite suppression and metabolic improvement.. This mechanism is particularly relevant during high-volume training phases when tissue repair demand exceeds the body's natural recovery capacity.
Variable — onset typically within 2–8 weeks depending on protocol and individual response.
Individual response varies based on injury severity, training load, and baseline health markers.
Nausea, vomiting, diarrhea common during titration. Rare: pancreatitis, thyroid C-cell tumors (animal data). Contraindicated in MEN2/medullary thyroid cancer.
Always verify current WADA status with your sport's governing body before use in competition.
https://pubmed.ncbi.nlm.nih.gov/28605608/
https://pubmed.ncbi.nlm.nih.gov/30122560/
Start a GLP-1 (Semaglutide) Protocol
Hatter Labs provides physician-supervised performance protocols with GMP-certified GLP-1 (Semaglutide) and comprehensive biomarker monitoring.
Get ProtocolCompare & Stack
Start Your Performance Protocol for GLP-1 (Semaglutide)
Hatter Labs provides physician-supervised performance protocols with GMP-certified compounds, biomarker testing, and personalized programs designed around your training goals.
HIPAA Compliant · GMP Certified · Physician Supervised